HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complementation Group G Xeroderma Pigmentosum

mutation in ERCC5
Also Known As:
Xeroderma Pigmentosum, Complementation Group G; Xeroderma Pigmentosum VII
Networked: 20 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
2. Complementation Group D Xeroderma Pigmentosum

Experts

1. Ibuki, Yuko: 2 articles (07/2022 - 01/2022)
2. Komaki, Yukako: 2 articles (07/2022 - 01/2022)
3. Bhattacharya, Deep: 1 article (08/2022)
4. Pal, Riasha: 1 article (08/2022)
5. Paul, Nilanjan: 1 article (08/2022)
6. Rakshit, Sudeshna: 1 article (08/2022)
7. Sarkar, Koustav: 1 article (08/2022)
8. Shanmugam, Geetha: 1 article (08/2022)
9. Suganuma, Koki: 1 article (07/2022)
10. Lans, Hannes: 1 article (03/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Complementation Group G Xeroderma Pigmentosum:
1. Proteins (Proteins, Gene)FDA Link
2. EndonucleasesIBA
3. DNA (Deoxyribonucleic Acid)IBA
4. Transcription Factor TFIIHIBA
5. Flap EndonucleasesIBA
6. PlatinumIBA
7. STAT1 Transcription FactorIBA
8. Recombinases (Recombinase)IBA
9. Messenger RNA (mRNA)IBA
10. Nucleic AcidsIBA

Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Treatment Delay